Roundtable Discussion: GE
This roundtable discussion duration is 30 minutes.
This roundtable discussion is designed to offer attendees the opportunity to connect directly with Industry Professionals to ask manufacturer-specific questions and learn more about the latest trends including neck-to-knee scans for body composition, TBS and more.
Global General Manager
Claudio Mejia is the Global General Manager for the Bone and Metabolic Health business segment for the GE Healthcare Women's Health business. In this role Claudio leads GE Healthcare’s global strategy and efforts to deliver innovative products to diagnose osteoporosis and metabolic health diseases. Claudio brings a wealth of experience with a solid background across Engineering, product management and business leadership. He started his career in 1993 in invasive cardiology and held various engineering roles focused in developing cathlab and electrophysiology products to diagnose and treat coronary artery disease. In 2016, Claudio joined the Bone and Metabolic Health business. As a proven innovator, Claudio has filed 15 patents and several have been incorporated into commercial products. He holds an advanced degree in Electrical Engineering in Digital Signal processing from the University of Kansas (USA) with a specialization in Artificial Neural Networks and an MBA from Loyola University in Chicago, IL (USA) with a specialization in Strategy and Finance.
Global Head & Sr. Director of A.I. for Women’s Health
Mario Lois is the Global Head & Senior Director of A.I./Intelligent Solutions for GE Healthcare Women's Health business. In this role Mario leads GE Healthcare’s global strategy and efforts to develop and apply Artificial Intelligence (AI) into world-class solutions that improve screening, diagnosis and treatment of Breast Cancer (the most common cancer among women). Mario brings a wealth of experience with a solid background across science, clinical applications, product management and business leadership. He started his career in 1998 in the cardiac ultrasound diagnostic imaging industry, mainly focused on advanced image analysis and quantification technologies at HP Medical, and at Philips Healthcare global headquarters in Andover, MA (US). Mario joined GE in 2003, and since then has held various international leadership roles at global and European level, including Europe General Manager for Vscan, EMEA Business/Product Manager for Compact Echocardiography, Global Director of Product Management, etc. More recently, in his prior role as Global General Manager for GE Healthcare Education Services, he built a global team and strategy to transform and digitize GE Healthcare’s customer education solutions, developing new digital platforms and innovative data-driven analytics for equipment utilization and outcomes optimization. He holds an advanced degree in Theoretical Physics from Universidad Autonoma in Madrid (Spain), a certificate in Strategic Management from Harvard University in Cambridge, MA (US), and a recent specialization in Deep Learning for A.I. from Dr. Andrew Ng’s Deeplearning.ai.
Engineering Manager Bone and Metabolic Health
Paul Markwardt is the Engineering Manager for the Bone and Metabolic Health business segment for GE Healthcare Women's Health business. In this role Paul leads a global engineering team to design and develop innovative products to diagnose osteoporosis and metabolic health diseases. Paul brings a wealth of experience with a solid background across engineering and clinical applications in DXA technology. He started his career in 1988 as a Software Research Engineer for Lunar Coporation and held various engineering roles within Lunar and later GE Healthcare focused on developing clinical applications and technology strategy for DXA products. As a proven innovator, Paul has filed 10 patents and co-authored numerous papers in the DXA field. He holds an advanced degree in Electrical and Computer Engineering from the University of Wisconsin Madison.
Diane Krueger, BS, CBDT (Moderator)
Program Manager Osteoporosis Clinical Research Program
UW Osteoporosis Clinic
Diane Krueger received her Bachelor of Science degree at the University of Wisconsin-Madison. She is an ISCD-certified clinical densitometrist and a certified clinical research coordinator through the Association of Clinical Research Professionals. She has been program manager of the University of Wisconsin Osteoporosis Clinical Research Program since its inception in 1993. Ms. Krueger has extensive clinical research experience in osteoporosis and bone densitometry, having coordinated multiple industry and investigator-initiated studies. In collaboration with the UW Osteoporosis Program, she has published over 90 manuscripts and authored or presented over 200 abstracts. Her service with ISCD has included serving as Technologist Bone Densitometry Course faculty since 2006 and chairing the related Update Annual Meeting Committees. In her leadership capacity, she is currently Education Council chair and serves on the Executive Committee and Board. Additionally, she previously held several officer positions including Secretary and four Presidential seats.
Disclosures: Consulting Fee: Amgen; Contracted Research: Radius